Cargando…
Current Status of Methods to Assess Cancer Drug Resistance
Drug resistance is the main cause of the failure of chemotherapy of malignant tumors, resistance being either preexisting (intrinsic resistance) or induced by the drugs (acquired resistance). At present, resistance is usually diagnosed during treatment after a long period of drug administration. In...
Autores principales: | Lippert, Theodor H., Ruoff, Hans-Jörg, Volm, Manfred |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3074090/ https://www.ncbi.nlm.nih.gov/pubmed/21487568 |
Ejemplares similares
-
Could a revision of the current guidelines for cancer drug use improve the quality of cancer treatment?
por: Lippert, Theodor H, et al.
Publicado: (2014) -
Prediction of Cancer Drug Resistance and Implications for Personalized Medicine
por: Volm, Manfred, et al.
Publicado: (2015) -
Protein expression profiles indicative for drug resistance of non-small cell lung cancer
por: Volm, M, et al.
Publicado: (2002) -
Development of drug resistance in a human epidermoid lung carcinoma xenograft line.
por: Mattern, J., et al.
Publicado: (1988) -
33. Methods used to assess implant stability - current status
por: Dole, Vinay
Publicado: (2018)